BBBT — Black Bird Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Black Bird Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.005	0.001	0.053	0.5	0.044
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.003	0.002
Total Inventory
Prepaid Expenses
Total Current Assets	0.005	0.001	0.106	0.678	0.135
Net Property, Plant And Equipment	—	—	—	0.012	0.007
Net Intangible Assets
Other Long Term Assets
Total Assets	0.005	0.001	0.126	0.774	0.219
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.02	1.14	0.099	0.104	0.869
Total Long Term Debt
Total Debt
Total Liabilities	1.02	1.14	0.099	0.104	0.869
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.02	-1.14	0.028	0.67	-0.65
Total Liabilities & Shareholders' Equity	0.005	0.001	0.126	0.774	0.219
Total Common Shares Outstanding
Total Preferred Shares Outstanding